| Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy AS Merseburger, N Agarwal, A Bjartell, H Uemura, AJ Soto, A Bhaumik, ... BJU international, 2024 | | 2024 |
| Therapiesequenzen und–dauer beim mCRPC: Eine retrospektive Aufarbeitung der Lübecker mCRPC-Kohorte M Müller, S Sarcan, A Offermann, D Kang, JR Wießmeyer, M Kramer, ... Aktuelle Urologie, 2024 | | 2024 |
| Therapy sequences and duration in mCRPC: a retrospective review of the Lübeck mCRPC cohort M Müller, S Sarcan, A Offermann, D Kang, JR Wießmeyer, M Kramer, ... Aktuelle Urologie, 2024 | | 2024 |
| Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma CN Sternberg, Y Loriot, E Choy, D Castellano, F Lopez-Rios, GL Banna, ... European Urology Focus, 2024 | | 2024 |
| Real-world outcomes and predictive biomarkers for 177Lutetium prostate-specific membrane antigen ligand treatment in metastatic castration-resistant prostate cancer: A European … M Kafka, A Horninger, G di Santo, I Virgolini, H Neuwirt, LM Unterrainer, ... European Urology Oncology 7 (3), 421-429, 2024 | 2 | 2024 |
| Proteomic analysis of the urothelial cancer landscape FF Dressler, F Diedrichs, D Sabtan, S Hinrichs, C Krisp, T Gemoll, ... Nature Communications 15 (1), 4513, 2024 | | 2024 |
| Current Potential for Outpatient Care in Urology: What the IGES Report Means if Applied to Real Data L Liedke, AS Merseburger, L Piest, C Wille, D Häckl, S Bettin, C Elsner Aktuelle Urologie, 2024 | | 2024 |
| Aktuelle Ambulantisierungspotenziale in der Urologie-was bedeutet das IGES Gutachten auf Echtdaten angewendet L Liedke, AS Merseburger, L Piest, C Wille, D Häckl, S Bettin, C Elsner Aktuelle Urologie, 2024 | | 2024 |
| Therapy Optimization in the Management of Metastatic Hormone-sensitive Prostate Cancer: Insights from the ARASENS Study. AS Merseburger, S Chowdhury, A Bahl European Urology, S0302-2838 (24) 02364, 2024 | | 2024 |
| Endoscopic intervention versus radical nephroureterectomy for the management of localized upper urinary tract urothelial carcinoma: a systematic review and meta-analysis of … C Giulioni, C Brocca, P Tramanzoli, S Stramucci, M Mantovan, L Perpepaj, ... World Journal of Urology 42 (1), 318, 2024 | | 2024 |
| Perception of cure in prostate cancer: human-led and artificial intelligence-assisted landscape review and linguistic analysis of literature, social media and policy documents E Efstathiou, A Merseburger, A Liew, K Kurtyka, O Panda, D Dalechek, ... ESMO open 9 (5), 103007, 2024 | | 2024 |
| MP14-09 DEVELOPMENT OF A PREDICTION MODEL OF SURVIVAL AMONGST PATIENTS WITH METASTATIC HORMONE SENSITIVE PROSTATE CANCER (MHSPC) USING BIG DATA: INTERIM RESULTS FROM THE … R Nicoletti, JG Rivas, L Ibáñez, C Steinbeisserc, B de Meulder, A Golozar, ... Journal of Urology 211 (5S), e223, 2024 | | 2024 |
| MP14-08 REAL-WORD CLINICAL CHARACTERIZATION OF METASTATIC HORMONE SENSITIVE PROSTATE CANCER: DATA FROM THE EUROPEAN NETWORK OF EXCELLENCE FOR BIG DATA IN PROSTATE CANCER (PIONEER) R Nicoletti, JG Rivas, L Ibáñez, C Steinbeisserc, B de Meulder, L France, ... Journal of Urology 211 (5S), e222, 2024 | | 2024 |
| Nierenzellkarzinom: Neue Studie zu Immuncheckpointinhibitoren plus Axitinib H Rexer, G von Amsberg, C Doehn Uro-News 28 (5), 44-45, 2024 | | 2024 |
| Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy: a meta-analysis. S Motlagh, A Ghoreifi, T Yanagisawa, T Kawada, S Ahyai, ... BJU international, 2024 | | 2024 |
| Large Language Modelle zur schnellen Vereinfachung der Eingabe von Qualitätssicherungsdaten: Performance-Test mit Echtdaten am Beispiel der Tumordokumentation in der Urologie J Frank, AS Merseburger, J Landmesser, S Brozat-Essen, P Schramm, ... Aktuelle Urologie, 2024 | | 2024 |
| Large Language Models for Rapid Simplification of Quality Assurance Data Input: Field Trial with Real Data in the Context of Tumour Documentation in Urology J Frank, AS Merseburger, J Landmesser, S Brozat-Essen, P Schramm, ... Aktuelle Urologie, 2024 | | 2024 |
| Retrospektive NIS-Studie zur HER2-Expression beim Urothelkarzinom H Rexer, A Merseburger, CH Ohlmann Forum 39 (2), 143-144, 2024 | | 2024 |
| Cardiovascular disease risk assessment and multidisciplinary care in prostate cancer treatment with ADT: recommendations from the APMA PCCV expert network AS Merseburger, G Bakshi, DY Chen, E Chiong, M Jabbour, JY Joung, ... World Journal of Urology 42 (1), 156, 2024 | | 2024 |
| Development of a predictive model for death amongst patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) treated with one of the approved treatment plans, on … R Nicoletti, JG Rivas, L Ibánez, C Steinbeisse, B de Meulder, H Ayman, ... European Urology 85, S1579-S1580, 2024 | | 2024 |
Milan HoraDept. of Urology, University Hospital Plzeň, CZ在 fnplzen.cz 的电子邮件经过验证
